Health The Sciences World What Explains the FDA’s Big Gamble on Aducanumab, the New Alzheimer’s Drug? C. Michael White 11/06/2021 0 If aducanumab is found to be ineffective, patients will...Read More
Health World Mixed Results From Trial, but FDA Approval for Alzheimer Drug Hailed as Victory Deena Beasley and Julie Steenhuysen 09/06/2021 0 The FDA's approval requires Biogen to conduct a confirmatory...Read More
